• Home
  • About Journal
    Journal Introduction
    Editorial Board
    Youth Editorial Board
    Cooperating Institutions
    Editorial Department
  • Submission Guidelines
  • Policies & Statements
    Ethical Guidelines for Publication
    Academic Misconduct Statement
    Open Access (OA) Statement
    AIGC Use Statement
  • Journal Subscription
  • Download Center
  • 中文版
Cite this article:
LU Mingying,HU Weiwei,GAO Xinghua.Research and development progress of anti-tumor drug targeting transcription factors[J].Journal Of Pharmaceutical Research,2024,43(1):83-88[Click to copy]
【Print this page】      【Download PDF Full Text】   【View/Add Comment】  【Download reader】  【 Close 】
←Previous|Next→ Archive    Advanced Search
This article has been viewed: 3027times   Download 2604次 QR Code for this article
Scan with your phone!
靶向转录因子的抗肿瘤药物研发进展
路明英,胡唯伟,高兴华
Font:Larger+|Default|Smaller-
(中国药科大学,江苏 南京 211198)
摘要:
转录因子(Transcription factor,TF)通过与DNA链上特定结合位点的结合,转录调控信号通路中不同蛋白的表达,进而参与调控多种细胞的正常生理过程,如细胞增殖、代谢、凋亡、免疫反应和分化等。TFs的异常表达促进了肿瘤的发生发展,以TFs为靶点成为药物研发的新思路。然而,结构紊乱和结合口袋的缺乏使得靶向TFs的药物设计具有挑战性。本综述将总结靶向TFs小分子药物开发的研究进展以及已经取得的一些成功案例,以证明靶向TFs成药的可行性。
关键词:  转录因子  抑制剂  TF-DNA相互作用  蛋白-蛋白相互作用  PROTAC
DOI:10.13506/j.cnki.jpr.2024.01.015
基金项目:国家自然科学基金(No.82073280)
Publication Date:January 25, 2024
Research and development progress of anti-tumor drug targeting transcription factors
LU Mingying,HU Weiwei,GAO Xinghua
(China Pharmaceutical University,Nanjing 211198,China)
Abstract:
Transcription factors control many normal cellular processes such as cell growth and proliferation, metabolism, apoptosis, immune response and differentiation by binding to DNA-regulatory sequences. TFs are often dysregulate in cancer and associate with initiation and progression of cancer. Therefore targeting TFs provides new ideas for the development of anticancer drugs. However, drug design targeting TFs faces challenges because of structural disorder and lack of binding pockets. This review focuses on the advances and successes in the development of small molecules targeting TFs and demonstrates feasibility of drug discovery targeting TFs and provides paradigms for the development of drugs targeting TFs.
Key words:  TFs  Inhibitors  TF-DNA interaction  Protein-protein interaction  PROTAC
Today's Visits:511    Total Visits:2383242
Website copyright:Editorial Board of Journal of Pharmaceutical Research     鲁ICP备17018036号-3     鲁公网安备 37010202001351号
Sponsored by:Shandong Institute for Food and Drug Control Shandong Pharmaceutical Association Address:No.2749 Xinluo Street,High-Tech Zone,Jinan,P.R.China Postcode:250101
Telephone Number:0531-81216586 Email :yaoxueyanjiu@163.com;yaoxueyanjiu@126.com
Technical Support:Beijing Qinyun Technology Co., Ltd.